BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37470584)

  • 1. Unusual histomorphological spectrum of urinary bladder cancers and their treatment modalities revisited: Our experience with series of five cases.
    Mohanty P; Mohapatra AS; Sabat D; Nayak J
    J Cancer Res Ther; 2023; 19(3):617-623. PubMed ID: 37470584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
    Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine carcinoma of the urinary bladder. 15-year retrospective analysis.
    Perán Teruel M; Giménez Bachs JM; Martínez Ruiz J; Fernández Anguita PJ; Nuñez Sarrión MA; Pastor Guzmán JM; Salinas Sánchez AS; Lorenzo Romero JG; Donate Moreno MJ; Atienzar Tobarra M; Virseda Rodríguez JA
    Arch Esp Urol; 2012 Mar; 65(2):237-43. PubMed ID: 22414452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience.
    Quek ML; Nichols PW; Yamzon J; Daneshmand S; Miranda G; Cai J; Groshen S; Stein JP; Skinner DG
    J Urol; 2005 Jul; 174(1):93-6. PubMed ID: 15947585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine small-cell bladder cancer: our experience].
    Ruoppolo M; Pezzica E; Milesi R; Corti D; Mercurio P; Fragapane G
    Urologia; 2010; 77 Suppl 17():64-71. PubMed ID: 21308678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
    Lonati C; Baumeister P; Ornaghi PI; Di Trapani E; De Cobelli O; Rink M; Karnes RJ; Poyet C; Simone G; Afferi L; Necchi A; Briganti A; Montorsi F; Krajewski W; Antonelli A; Cerruto MA; Zamboni S; Simeone C; Mordasini L; Mattei A; Moschini M;
    Eur Urol Focus; 2022 Mar; 8(2):457-464. PubMed ID: 33867307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
    Porten SP; Willis D; Kamat AM
    Curr Opin Urol; 2014 Sep; 24(5):517-23. PubMed ID: 24921905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component.
    Yasui M; Morikawa T; Nakagawa T; Miyakawa J; Maeda D; Homma Y; Fukayama M
    Pathol Res Pract; 2016 Sep; 212(9):833-7. PubMed ID: 27461832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
    Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
    J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes.
    Mistretta FA; Negrean-Dzyuba C; Palumbo C; Pecoraro A; Knipper S; Tian Z; Musi G; Montanari E; Perrotte P; Briganti A; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
    Int J Urol; 2020 May; 27(5):402-407. PubMed ID: 32172530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The demographic features, clinical outcomes, prognosis and treatment options for patients with sarcomatoid carcinoma of the urinary bladder: a single centre experience.
    Robinson SP; Farooq A; Laniado M; Motiwala H
    Int Braz J Urol; 2018; 44(1):45-52. PubMed ID: 29064650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
    Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection.
    Seisen T; Compérat E; Léon P; Roupret M
    Curr Opin Urol; 2014 Sep; 24(5):524-31. PubMed ID: 25051021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature.
    Carrion-Ballardo CJ; Gala-Solana L; Portillo-Martin JA; Azueta-Etxebarria A; Truan-Cacho D; Campos-Juanatey F
    Actas Urol Esp; 2015; 39(6):387-91. PubMed ID: 25670479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases].
    Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report.
    Prelaj A; Rebuzzi SE; Magliocca FM; Speranza I; Corongiu E; Borgoni G; Perugia G; Liberti M; Bianco V
    Am J Case Rep; 2016 Apr; 17():248-53. PubMed ID: 27072610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of bladder urothelial carcinoma with squamous differentiation.
    Raman JD; Jafri SM
    Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.